December 6, 20234Suministradora de Buses K Cuatro’s US$344 Millon Financing for Electric Bus Fleet in Chile
December 6, 20234Eneti Inc’s $436 Million Green Senior Secured Credit Facility For Wind Turbine Installation
December 5, 20234Wilmar Group’s Divestment of its Stake in Cosumar to a Consortium of Moroccan Investors
December 5, 20234Hall & Wilcox significantly expands projects and infrastructure capability with appointment of two new partners
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
May 30, 20234Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant
December 5, 20234Hall & Wilcox significantly expands projects and infrastructure capability with appointment of two new partners
Homepage Europe Europe Legal Chronicle Coave Therapeutics’ €21 Million Funding Round Coave Therapeutics’ €21 Million Funding Round August 2, 2021 Naoual Sadouqi Tagged: Anthony Paronneau Bird & Bird Coave Therapeutics (Horama SAS) Emmanuelle Porte Frédéric Cazals Fund+ Go Capital Gotshal & Manges Idinvest Partners Jasmine Javault Kurma Partners Laetitia de Dinechin McDermott Will & Emery Omnes Capital Pascaline Sagot Seroba Life Sciences Sham Innovation Santé Sylvie Hamel Théa Open Innovation V-Bio Ventures Weil IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter.Bird & Bird advised Coave Therapeutics (Horama SAS) with a… This content is for Standard 1 Year members only.Login Join Now